Cargando...
A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm with 5-year survival as low as 6%. It is therefore imperative to explore potential treatment avenues to improve survival in these groups of patients. Anti-estrogenic hormone therapy (AEHT) is well-tolerated an...
Gardado en:
| Publicado en: | Transl Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724184/ https://ncbi.nlm.nih.gov/pubmed/33409403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2020.02.16 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|